Running out of patience sounds like a PROBLEM that only affects one trading account of an impatient shareholder...
(Although there may be many other traders who picked the wrong entry point and had incomplete DD and unrealistic expectations.)
those with experience in holding biotech start-ups PATIENTLY WAITING for the PAY OFF will not have a PROBLEM CONTINUING TO MONITOR ONVO until the promise of its amazing 3D bioprinting technology can be realized and add the appropriate VALUE to the shares in many accounts!!
Market Data 
Markets 
AI
